NIH RPPRs Select Items Requiring Extra Attention

Page Updated: March 14, 2023

Introduction

RSP often receives questions after an NIH RPPR has been submitted. To help people prepare sufficiently thorough reports, this page contains guidance on completing those sections that generate the most questions. Progress reports require careful attention and should contain enough information to help NIH assess the project’s status. If you provide a thorough report to the NIH, that should facilitate the review of the report and the release of the next year’s funding.

High-Level Tips

  • NIH Instructions: See the NIH and Other PHS Agency Research Performance Progress Report (RPPR) Instructional Guide for official guidelines
  • Upcoming (or Past Due) Reports:Check one or both of the following tools to find out what progress reports are pending or, if applicable, past due.
    • Pending Progress Reports: This is a tool in eRA Commons that provides a list of progress reports for an institution due within the next 4 months. The IPF Number for UW-Madison is 578503.
    • NIH Award Deliverables: On the Divisional Dashboard, there is a link to a list of all reports that may be pending submission or acceptance by NIH.
  • When to begin report: Start the progress report as EARLY as possible.
  • Interim RPPR: If the PI has submitted a renewal application on or before the date by which a Final Research Performance Progress Report would be required for the current competitive segment, then submission of an Interim RPPR via eRA Commons is required.
  • Routing the report:
    • All RPPRs must be routed in RAMP. See Routing Guidance here
  • Post-submission questions: PIs and departments must be prepared to respond to questions on the progress report from the NIH Grants Management Specialist (GMS). The GMS may provide very little time to respond to questions.

Section-Specfic Tips

Section A - Cover Page

A.2 - Signing Official Information
  • EGAN, BRENDA
A.3 - Administrative Information
  • EGAN, BRENDA
A.4 - Recipient ID
  • (Optional) Enter institution number for PD progress report record.

Section B - Accomplishments

B
  • This section is used by the agency to assess whether satisfactory progress has been made during the reporting period. NIH looks closely at Accomplishments, so please provide sufficient information for their assessment.
B.3 - Competitive Revisions or Administrative Supplements
  • Include information pertaining to your Revision or Administrative Supplement if you have a component.
B.4 - What opportunities for training and professional development has the project provided?
  • UW-Madison Individual Development Plan Standard Language for NIH RPPR (click here for a Word version of the paragraph below):

    The University of Wisconsin-Madison requires that all graduate students and postdoctoral researchers supported by NIH funding utilize Individual Development Plans to set academic and career goals and facilitate conversations with their mentors. Additionally, the university recommends that all graduate students and postdoctoral researchers utilize IDPs, regardless of funding source. The university offers a collection of resources and tools to support mentees, mentors, and PIs in implementing IDPs. These include a UW-Madison IDP template, workshops for mentees (both face-to-face and online videos), peer learning groups for mentees, as well as guidelines for mentors. More information can be found here: http://grad.wisc.edu/pd/idp. IDP activity for NIH-funded graduate students and postdoctoral researchers is tracked in the university’s IDP reporting system, a tool that maintains mentee privacy yet allows mentors and PIs to monitor IDP-related activity.

Section C - Products

C.1 - Publications
  • Note that PIs cannot enter information about publications directly into the RPPR record. They must keep publications up to date and compliant with the Public Access policy via My NCBI. If their publications are not compliant, they will receive warnings upon RPPR submission and be required to ensure compliance prior to award issuance.
  • PI sends publications to Public Access Service (PAS) at publicaccess@wisc.edu and PI will work directly with them. The RSP Proposal team submits the final compliance notification to sponsor.
  • Step-by-step: https://pas.wisc.edu/nih-non-compliance-notice/

Section D - Participants

D.1 - Individuals who have worked on the project
  • Names and effort of all personnel that have worked at least one person-month on the project during the reporting period, regardless of the source of compensation.
  • Use the appropriate person months (calendar, academic, and/or summer months), to 1 decimal place (e.g., 1.2 months).
  • The PD/PI’s effort must be listed even if it was less than 1.0 calendar month.
  • As a reminder, all PD/PIs on NIH awards are required to have measurable effort.
  • A Commons ID is required for all individuals with a postdoctoral, graduate or undergraduate role (NOT-OD-13-097). The Commons ID is also required for individuals supported by a Reentry or Diversity Supplement. Departments should contact the Dean’s office to create a Commons ID or to associate UW-Madison to an existing Commons ID.
D.2.C - Changes in Other Support
  • Usually applicable. Use updated OS documents to complete this section.
  • Provide acting and pending support for all new senior/key personnel.
  • Provide updated other support for all senior/key personnel for whom there has been a change in active other support.
  • Double check that people are not over committed and if they are, provide overlap justification summary with specifics on how it will be resolved.

Section E - Impact

E
  • N/A or Provided by PI, except…
E.4 - What is being spent in foreign countries

Section F - Changes

F.2 - Actual or anticipated challenges or delays and actions or plans to resolve them
  • Describe only significant challenges that may impede the research (e.g., accrual of patients, hiring of personnel, need for resources or research tools) and emphasize their resolution. If you plan to indicate in G.10 that there is an unobligated balance of 25% or more, then use F.2 to describe factors that may have contributed to the unobligated balance.

Section G - Special Reporting Requirements

G.4 - Human Subjects
  • Needs to be completed in ASSIST and moved to “Ready for Submission” to allow final submission.
  • New HS information requires updating the status of the prior ASSIST record to Work in Progress. Work in Progress allows the enrollment report to be added.
G.8 - Project/Performance Sites
  • Delete any duplicate sites.
  • The Primary Performance Site should be the PI’s building/lab.
G.9 - Foreign Component
  • See NIH Foreign Component Guidance.
  • Complete in conjunction with PI if applicable. See: https://grants.nih.gov/faqs#/research-performance-progress-report.htm?anchor=question53255
  • Provide Organization, Name, Country and Description of each foreign component.
  • The following grant-related activities are significant and must be reported:
    • involvement of human subjects or research with live vertebrate animals;
    • extensive foreign travel by grantee project staff to collect data, or conduct surveys or sampling activities; or
    • any grantee activity that may have an impact on U.S. foreign policy.
  • Examples of other grant-related activities that may be significant are:
    • collaborations with investigators at a foreign site anticipated to result in co-authorship;
    • use of facilities or instrumentation at a foreign site; or
    • receipt of financial support or resources from a foreign entity
G.10 Estimated Unobligated Balance
  1. The “total approved budget” includes the amount awarded for the current year and any authorized carryover from the previous budget period. If the unobligated balance is greater than 25% of this amount, an explanation and a plan for expenditure of those funds in the next budget period is needed.
    • To help estimate your unobligated balance, RSP has put together an unobligated balance worksheet. If you have any questions or concerns, please reach out to your accountant.
    • If you are anticipating that the remaining balance on an award may be close to 25% with carryover considered, it is suggested that Question G.10.a be answered yes.
  2. An ideal justification should be able to explain why funds would remain at the end of the year.
    • Any unanticipated delays with suppliers, delays with hiring, or other issues should be addressed.
    • The justification should state the balance as of the new year. The NIH is aware that this is an estimate and can change.
  3. Please check your Notice of Award to see if carryover requires Grants Management Officer approval. If it does, Question G.10.c is not a formal request for carryover into the proceeding year. If carryover is anticipated, a general description of what may be planned for the carryover can be listed. After the grant year is complete, the final unobligated balance is calculated during the expenditure review process and a formal request should be sent to the Grants Management Specialist. As the unobligated figure is finalized and the financial report is submitted, please work with your RSP accountant to draft the carryover request. This does not need to go through RAMP. RSP will submit as an Authorized Official.
    • If carryover does not require grants management officer approval, please provide a general description of how it is anticipated that the funds will be spent, according to the grant timeline. If you have any questions or concerns, please reach out to your accountant.

Any inquiries received from the NIH as a result of an RPPR submission should be directly responded to by RSP. The NIH requires institutional concurrence.

G.11 - Program Income
  • Complete. Almost always No.
G.12 - F&A Costs
  • Complete if change in subaward location will change F&A costs.